Liver Foundation, West Bengal, is a voluntary, non-government organization (NGO) registered under the Societies Act 1961. It was founded on June 30, 2006 by a group of health professionals and social activists. Its primary objective is to take the benefits of the advances of medical sciences to the economically deprived sections of India.
Liver Foundation West Bengal aims at reaching the mass and increase awareness in liver health problems and associated disorders, with the purpose of reducing liver disorders in India, with proper access to medical science, focusing on liver diseases but also at a wider scale in public health. They aim to enhance the quality of life and try to reduce the burden of liver disease in India through prevention, education, advocacy, improved care and promotion of concepts in public health.
We pledge to surge ahead remaining in our cultural inheritance with the philosophy of welfare, keeping in focus the priorities of our country. Liver, its diseases, care & treatment, above all liver transplantation, has always remained out of the reach of the common people.
Liver Foundation West Bengal´s primary focus is to take benefits of the advancement of medical sciences to the economically deprived sections of society.
Our key goals are :
To spread awareness among the people at large about various aspects of liver diseases in a parlance that is easily understandable,
To identify the socio-cultural roots of the existing inequity within India´s healthcare system, in terms of access, organisation and functioning, and
To facilitate the availability of the technology-dense advanced medical care in liver diseases to people who are unable to afford it.
Hepatitis and PWID/harm reduction
11:35 – 11:40
Chair: WHO – Intro and set the scene.
11:40 – 11:55
Co-chair: EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe.
11:55 – 12:00
ID 29: Ema Pos (not yet registered)
Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation.
12:05 – 12:10
ID 152: Brian Conway (Registered in person)
Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.
12:10 – 12:15
ID 212: Jasmine West (not yet registered)
Title: From lived experience to lived expertise: a syndemic approach.
12:15 – 12:20
ID: 299 Mercy Nyakowa (Registered in person)
Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya
12:20 – 12:25
ID: 133 Nalinikanta Rajkumar (Registered in person)
Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?
12:25 – 12:30
Q&A and closing remarks
tHIS
IS
BEN’S
BIG
TEST
effective case finding strategies
Supported by Vir Biotechnology, Inc
During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.
Session Agenda
14:40 – 14:45
Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)
14:45 – 15:05
Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology
15:05 – 15:10
Final remarks and close